L. Grubert et al. / Tetrahedron 65 (2009) 5936–5944
5943
4.3.3. 11,23-Di-(9-methoxy-9,10-dihydro-N-methylacridine-9-yl)-
25,27-dihydroxy-26,28-bis-(propyloxy)calix[4]arene-crown-4
cone (4)
The remaining residue was dissolved in acetonitrile (mL) and
treated with NH4PF6 (2.5 g). The solution was evaporated in
vacuo. The remaining solid was washed with water and MTBE.
The crude product was purified by CC (acetonitrile/ethylacetate/
cyclohexane/NH4PF6 400 mL/200 mL/100 mL/1 g); yellow crys-
tals, 0.96 g (36%), mp 208–210 ꢀC. Anal. C70H72N2O8P2F12
(1359.25); HRMS (ESI, pos., MeCN): [MꢁPFꢁ6 ]þ calcd for
C70H72N2O8PF6: 1213.4931, found: 1213.4913; [Mꢁ2PFꢁ6 ]2þ calcd
for C70H72N2O8: 534.2644, found: 534.2645. 1H NMR (400 MHz,
A suspension of 3 (0.11 g, 0.1 mmol) in acetonitrile (9 mL) and
methanol (1 mL) and K2CO3 (0.10 g) was stirred at room temper-
ature for 5 h. After filtration the solvents were removed in vacuo.
The residue was treated with dry chloroform (10 mL) and then
filtered. The filtrate was evaporated in vacuo. After recrystallization
(acetone) a colorless solid was obtained, 0.85 g, (79%), mp¼192–
195 ꢀC. Anal. C70H72N2O8 (1069.36); HRMS (ESI, pos., MeOH):
[MþNaþ]þ calcd for C70H72N2O8Na: 1091.5186, found: 1091.5198;
[MꢁOCHꢁ3 ]þ calcd for C69H69N2O7: 1037.5105, found: 1039.5122;
[Mꢁ2OCHꢁ3 ]2þ calcd for C68H66N2O6: 503.2460, found: 503.2468.
CD3CN, TMS):
d
¼acridinium: 8.51 (d, J¼9.0 Hz, 2H, H-5), 8.41
(ddd, 3J¼9 Hz, 3J¼8 Hz, 4J¼1 Hz, 2H, H-6) 8.20 (dd, 3J¼8.8 Hz,
4J¼1 Hz, 2H, H-8), 7.91 (ddd, 3J¼9 Hz, 3J¼8 Hz, 4J¼1 Hz, 2H, H-7),
7.83 (d, J¼9.0 Hz, 2H, H-4), 7.00 (dt, 3J¼9 Hz, 4J¼1 Hz, 2H, H-3),
6.22 (t, J¼8 Hz, 2H, H-2), 5.89 (dd, 3J¼8 Hz, 4J¼1 Hz, 2H, H-1) 4.56
(s, 6H, –Nþ–CH3); calixarene: 7.17 (d, J¼7.3 Hz, 4H, H-4, 5, 16, 18),
6.77 (t, J¼8 Hz, 2H, H-5, 17), 6.74 (s, 4H, H-10, 12, 22, 24), 5.31 (s,
4H, –OCH2O–), 4.67 (d, 4H, 2J¼13.3 Hz, H-2, 8, 14, 20), 4.20 (m,
4H, –OCH2CH2CH3), 4.06 (m, 4H, –OCH2OCH2CH2OCH3), 3.62 (m,
4H, –OCH2OCH2CH2OCH3), 3.55 (d, 4H, 2J¼13.3 Hz, H-2, 8, 14, 20),
3.35 (6H, –OCH2OCH2CH2OCH3), 2.25 (m, 4H, –OCH2CH2CH3), 1.06
(t, 6H, –OCH2CH2CH3). 13C NMR (100 MHz, CDCl3, TMS)
1H NMR (400 MHz, CD3CN, TMS):
d¼acridane: 7.35 (t, 4H, J¼7.8 Hz,
H-1, 8), 7.28 (d, 4H, J¼7.8 Hz, H-2, 7), 7.16 (d, 4H, J¼7.8 Hz, H-4, 5),
6.95 (t, 4H, J¼7.8 Hz, H-3, 6) 3.51 (s, 6H, –N–CH3) 3.01 (s, 6H,
–OCH3); calixarene: 7.09 (s, 4H, H-10, 12, 20, 24), 6.74 (d, 4H,
J¼7.5 Hz, H-4, 6, 16, 18), 6.61 (t, 2H, J¼7.5 Hz, H-5, 17), 4.21 (d, 4H,
H-2, 8, 14, 20), 3.33 (d, 4H, H-2, 8, 14, 20); crown: 4.01 (m, 8H,), 3.91
(s, 4H); ether: 4.01 (m, 4H, –OCH2CH2CH3), 1.75 (m, 4H,
–OCH2CH2CH3), 0.82 (t, 6H, 3J¼7.5 Hz, –OCH2CH2CH3). 13C NMR
(100 MHz, CD3CN, TMS):
d¼acridane: 141.2 (C-4a, 5a), 129.1 (C-1,
d
¼acridinium: 140.9, 139.7, 138.6 (C-6), 136.2, 135.5 (C-3), 134.9,
8), 128.3 (C-3, 6), 124.3 (C-1a, 8a), 120.4 (C-2, 7), 113.1 (C-4, 5), 78.7
(C-9), 51.1 (–OCH3), 33.4 (–NCH3); calixarene: 152.3 (C-25, 27), 151.7
(C-26, 28) 147.2 (C-11, 23), 135.7 (C-1, 9, 13, 21), 134.5 132.5 (C-3, 7,
15, 19), 128.9 130.0 (C-4, 6, 16, 18), 126.6 128.2 (C-10, 12, 20, 24),
125.7 121.4 (C-5, 17), 73.8 (–OCH2CH2CH3), 29.9 (C-2, 8, 14, 20), 22.1
(–OCH2CH2CH3), 9.0 (–OCH2CH2CH3); crown: 79.0 (2C, CH2), 70.0
(4C, CH2).
130.6 (C-8), 129.2 (C-1), 127.7 (C-7), 125.4 (C-2), 124.6, 123.3, 117.9
(C-5), 116.7 (C-4), 38.2 (–Nþ–CH3); calixarene: 132.1 (C-10, 12, 22,
24), 128.9 (C-4, 5, 16, 18), 123.0 (C-5, 17), 99.8 (–OCH2O–), 76.7
(–OCH2CH2CH3), 71.4 (–OCH2CH2OCH3), 69.4 (–OCH2CH2OCH3),
57.8 (–OCH2CH2OCH3), 30.6 (C-2, 8, 14, 20), 22.9 (–OCH2CH2CH3),
9.2 (–OCH2CH2CH3).
4.3.6. 11,23-Di-(N-methylacridinium-9-yl)-25,27-hydroxy-26,28-
4.3.4. 11,23-Di-bromo-25,27-bis(2-methoxy-ethoxymethoxy)-
26,28-bis(propyloxy)calix[4]arene (5)
bis(propyloxy)calix[4]arene bis hexafluorophosphate (7)
Compound
6 (0.30 g, 0.22 mmol) dissolved in acetonitrile
Butyllithium (6.5 mL 1.6 M in hexane, 10.4 mmol) was added to
a solution of 1 (3.33 g, 5 mmol) in THF (125 mL). After stirring for
0.5 h methoxyethoxymethyl chloride (MEM chloride, 1.25 g,
10 mmol) in THF (20 mL) was added. The solution was stirred at
room temperature for 3 h. The solvent was removed in vacuo. The
residue was dissolved in chloroform (100 mL) and washed with
water (4ꢂ50 mL). After drying (MgSO4) the solution was evapo-
rated. The remaining solid was purified by recrystallization (n-
hexane), 3.8 g (90%), mp 102–104 ꢀC. Anal. Calcd for C42H50Br2O8
(842.66): C, 59.87; H, 5.98; Br, 18.96. Found: C, 60.12; H, 6.05; Br,
(25 mL) was treated with HPF6 (0.2 mL) and water (0.4 mL) under
stirring for 1 h. After evaporating the solution, the remaining solid
was washed with water (5 mL) and MTBE (10 mL). The remaining
solid was purified by CC (acetonitrile/ethylacetate/cyclohexane/
NH4PF6 400 mL/200 mL/100 mL/1 g), 0.195 g (75%), orange solid,
mp¼325 ꢀC. Anal. C62H56 F12N2O4P2 (1183.03); HRMS (ESI, pos.,
MeCN): [MꢁPF6ꢁ]þ calcd for C62H56N2O4PF6: 1037.3882, found:
1037.3869; [Mꢁ2PF6ꢁ]2þ calcd for C62H56N2O4: 446.2120, found:
446.2117. 1H NMR (600 MHz, (CD3)2CO, TMS):
d
¼acridinium: 8.80
(d, 2H, 3J¼7.2 Hz, H-5), 8.77 (d, 2H, J¼7.2 Hz, H-4), 8.42 (t, 2H,
3J¼7.2 Hz, H-6), 8.39 (t, 2H, 3J¼7.2 Hz, H-3), 8.31 (d, 2H, 3J¼8.4 Hz,
H-8), 8.11 (d, 2H, 3J¼8.4 Hz, H-1), 7.93 (t, 2H, 3J¼8.4 Hz, H-7), 7.84 (t,
2H, 3J¼8.4 Hz, H-2), 5.00 (s, 6H, –Nþ–CH3); calixarene: 9.38 (s, 2H,
OH), 7.53 (s, 4H, H-10, 12, 22, 24), 7.08 (d, 4H, 3J¼7.5 Hz, H-4, 6, 16,
18), 6.80 (t, 2H, 3J¼7.5 Hz, H-5, 17), 4.48 (d, 4H, 2J¼13.0 Hz, H-2, 8,
14, 20), 4.08 (t 4H, 3J¼5.8 Hz, –OCH2CH2CH3), 3.67 (d, 4H,
2J¼13.0 Hz, H-2, 8, 14, 20), 2.13 (m, 4H, –OCH2CH2CH3), 1.40 (t, 6H,
3J¼7.3 Hz, –OCH2CH2CH3). 13C NMR (75 MHz, CD3CN, TMS):
19.02; 1H NMR (400 MHz, CDCl3, TMS):
d¼7.18 (s, 4H, H-10, 12, 22,
24), 6.33 (t, 3J¼7.5 Hz, 2H, H-5, 17), 6.19 (d, 3J¼7.5 Hz, 4H, H-4, 5, 16,
18), 5.23 (s, 4H, –OCH2O–), 4.36 (d, 4H, 2J¼13.6 Hz, H-2, 8, 14, 20),
3.95 (m, 4H, –OCH2OCH2CH2OCH3), 3.64 (t, 4H, 3J¼7.3 Hz,
–OCH2CH2CH3), 3.54 (m, 4H, –OCH2OCH2CH2OCH3), 3.36 (s, 6H,
–OCH2OCH2CH2OCH3), 3.11 (d, 4H, 2J¼13.6 Hz, H-2, 8, 14, 20), 1.79
(m, 4H, –OCH2CH2CH3), 1.00 (t, 6H, 3J¼7.5 Hz, –OCH2CH2CH3). 13C
NMR (100 MHz, CDCl3, TMS):
138.8 (C-1, 9, 13, 21), 132.4 (C-3, 7, 15, 19), 131.4 (C-10, 12, 22, 24),
d
¼155.1 (C-25, 27), 154.7 (C-26, 27),
d
¼acridinium 161.9,155.0,151.9,141.4,138.3 (C-6),138.1 (C-3),133.5,
127.9 (C-4, 5, 16, 18), 122.6 (C-5, 17), 115.4 (C-11, 23), 98.9 (–OCH2O),
130.5 (C-8), 130.0 (C-1), 128.4, 127.3 (C-7, 2), 125.8 (C-8a, 9a), 118.2
(C-5), 118.1 (C-4); calixarene 131.0 (C-10,12, 22, 24),129.1 (C-4, 6,16,
18), 125.9 (C-5, 17), 123.8 (C-11, 23), 78.5 (–OCH2CH2CH3), 38.3
(–Nþ–CH3), 30.3 (C-2, 8, 14, 20), 23.1 (–OCH2CH2CH3), 10.1
(–OCH2CH2CH3).
76.7
(–OCH2CH2CH3),
72.2
(–OCH2OCH2CH2OCH3),
69.7
(–OCH2OCH2CH2OCH3), 59.1 (–OCH2OCH2CH2OCH3), 31.0 (C-2, 8,
14, 20), 23.3 (–OCH2CH2CH3), 10.6 (–OCH2CH2CH3).
4.3.5. 11,23-Di-(N-methylacridinium-9-yl)-25,27-bis(2-methoxy-
ethoxymethoxy)-26,28-bis(propyloxy)calix[4]arene bis
4.3.7. 11,23-Di-(9-methoxy-N-methylacridine-9-yl)-25,27-
hexafluorophosphate (6)
hydroxy-26,28-bis(propyloxy)calix[4]arene (8)
A solution of 5 (2.11 g, 2.5 mmol) in dry THF (150 mL) was
cooled to ꢁ78 ꢀC under argon. Butyllithium (3.13 mL 1.6 M solu-
tion in hexane, 5.01 mmol) dissolved in THF (8 mL) was added
dropwise. The reaction mixture was stirred at ꢁ78 ꢀC for 0.5 h. N-
Methylacridone (1.05 g, 5.02 mmol) was added. The reaction
mixture was slowly warmed to room temperature under argon.
Water (1 mL) was added. The solvents were removed in vacuo.
The suspension of 7 (0.050 g, 0.48 mmol) and KHCO3 (0.05 g) in
acetonitrile (4 mL) and methanol (1 mL) was stirred for 5 days. The
product precipitated and was filtrated together with KHCO3. The
solid was washed with water until the water was neutral. The solid
was dried and recrystallized from acetonitrile, 0.037 g (75%),
mp¼148 ꢀC (dec). Anal. C64H62N2O6 (955.22); HRMS (ESI, pos.,
MeOH): [Mꢁ2MeOꢁ]2þ calcd for C62H56N2O6: 446.2120, found: